8,331 source-backed health facts - each attributed to a named person and a number, linked to the original source. Page 51 of 84.
“According to the American Gastroenterological Association (AGA), a healthcare team should monitor people with AHP annually for liver disease.”
“Beginning at age 50 years, people with AHP should be screened for hepatocellular carcinoma, an aggressive form of primary liver cancer. This should be performed via liver ultrasound every 6 months.”
“Those receiving active treatment for AHP should also be screened annually for chronic kidney disease.”
“In 2019, the FDA approved givosiran (Givlaari), which can significantly reduce episodes by inhibiting a liver gene called ALAS1.”
“After a gradual adjustment period, the Hyqvia dose is 300-600 mg/kg, every 3 to 4 weeks.”
“Typical monthly doses range from 0.4 to 2.4 g per 1 kg of body weight.”
“Hyqvia infusions are given every 2 to 4 weeks, often mirroring the previous IV schedule.”
“If needed, the dose will be gradually increased over 9 weeks until the target maintenance dose is reached.”
“The immune globulin infusion is a 10% solution, which means:”
“you need 0.5 mL of the enzyme for every 10 mL of the IgG medication (or 80 units of the enzyme for every 1 g of the IgG medication).”
“Hyqvia is available in five strengths, so the dose can match different body weights:”
“Hyqvia is typically administered by infusion every 3 to 4 weeks.”
“As of February 2026, only Wegovy and Rybelsus are available in pill form.”
“The Food and Drug Administration (FDA) has approved oral formulations of Wegovy and Rybelsus.”
“Research shows that oral semaglutide typically has a bioavailability of just 0.4% to 1%.”
“In early February 2026, Novo Nordisk decided to rename the R2 formulation to the Ozempic Pill, which will be available in the second quarter of the year.”
“Both oral and injectable semaglutide remain in the bloodstream for around 5 weeks after a person’s last dose.”
“The mean weight loss in the semaglutide group was 13.6%, compared with 2.2% in the placebo group.”
“The participants taking semaglutide had a mean weight loss of 15.1% compared to 2.4% in the placebo group.”
“They can switch from 2.4 mg injection to the 25 mg tablets with a 1-week break in between their last injection and their first oral Wegovy dose.”
“According to Eohilia’s prescribing information, the most common side effects of the drug that occurred in 3% of patients or more are:”
“To reduce the risk of more severe side effects, doctors typically only prescribe Eohilia for a limited time period of 12 weeks.”
“At the 3-month mark, you can expect to see a significant reduction in your LDL cholesterol.”
“Based on Repatha’s clinical trials, people taking the drug for 3 months experienced a substantial decrease in LDL cholesterol.”
“Most people see a significant drop in their cholesterol levels within the first three months of treatment.”
“It is responsible for an estimated 80% of lung cancer cases.”
“However, about 12.5% of people who develop lung cancer have never smoked.”
“According to a review of 57 studies that included different lung cancer populations from around the world, EGFR alterations were found in about half of people with Asian ancestry, compared with about 12.5% of people with European ancestry.”
“EGFR alterations are seen in about half of people with East Asian ancestry compared to one-third of people of South Asian ancestry.”
“In one study of people with adenocarcinoma, about two-thirds of women had EGFR alterations compared to about one-third of men.”
“some research suggests it may be more common in younger adults, particularly those age 55 and under.”
“In December of 2025, the Food and Drug Administration (FDA) approved Wegovy as an oral tablet.”
“At their full maintenance doses, average semaglutide levels in the body are similar between the Wegovy 25 mg daily tablet and the 2.4 mg weekly injection in adults.”
“as little as $25 per month”
“25 mg daily pill produces results similar to the 2.4 mg weekly injection”
“lost an average of 14% of their body weight over 64 weeks”
“lost an average of 15% of their body weight over 68 weeks”
“The Food and Drug Administration (FDA) has approved Penmenvy vaccine to help prevent meningitis A, B, C, W, and Y in children and adults ages 10 to 25 years old.”
“You will receive two doses of Penmenvy. These will be given 6 months apart from each other.”
“MCL makes up approximately 5% of all non-Hodgkin lymphomas.”
“most people are diagnosed at around 60 to 70 years of age.”
“BTK inhibitors can be taken at home, by mouth, once or twice daily.”
“The typical Eohilia dosage for adults with eosinophilic esophagitis is 2 mg taken twice per day for 12 weeks.”
“Eohilia is used to help treat eosinophilic esophagitis in children ages 11 years and older is the same as the dose for adults: 2 mg taken twice per day for 12 weeks.”
“Eohilia is typically a short-term treatment of 12 weeks.”
“The dosage of the drug is 2 mg taken twice per day, and your doctor may prescribe it for up to 12 weeks.”
“Eohilia can be prescribed for adults and children ages 11 years and older.”
“Truvada takes 7 days of daily use to reach the maximum effectiveness for receptive anal sex”
“Truvada takes 21 days of daily use for receptive vaginal sex”
“3-5 days of daily use isn’t enough time for the drug to reach its full effectiveness for either receptive anal or receptive vaginal sex”
“Truvada will clear from the bloodstream after 2–5 days of stopping the drug”
“Your protection from PrEP may remain for 7-10 days, depending on how long you have been taking Truvada or if you have other health factors, such as kidney problems, that affect how well your body breaks down the drug”
“have not had a period for 1 year.”
“between 45 and 55 years of age.”
“skin loses about 30% of its collagen in the first 5 years after menopause and another 2% per year for the next 20 years.”
“as much as a three-times-greater risk of depression and anxiety than those without eczema.”
“Biologics for AD treatment come in injectable form, and a person can inject a dose once or twice per month.”
“In 2024, an over-the-counter probiotic for eczema became available under the brand name Defensin.”
“In clinical studies, people taking Zepbound lost the most weight within the first 8 months of treatment.”
“In these studies, 7.1% of females experienced hair loss, compared to 0.5% of males.”
“Researchers considered a side effect to be “common” if it occurred in 5% or more participants.”
“Hair loss from Zepbound is usually temporary. Your hair should begin to grow back as usual within a few months as your body weight becomes more stable.”
“MenQuadfi protects against four of the most common serogroups found worldwide: A, C, W, and Y.”
“In the United States, the Food and Drug Administration (FDA) has approved MenQuadfi for people ages 6 weeks and older.”
“If standard treatments like artificial tears or therapeutic contact lenses have not healed a person’s corneal defect after 2 weeks, doctors typically consider Oxervate a first-line treatment to address the underlying nerve issue.”
“The treatment regimen for Oxervate is intensive but only lasts for 8 weeks.”
“The standard dosage is 1 drop in the affected eye, 6 times per day, at 2-hour intervals.”
“If you use other eye drops, wait at least 15 minutes between using them and Oxervate.”
“The most common is eye pain, which was reported in 16% of people in clinical trials.”
“In two clinical trials, about 70% of people treated with Oxervate had complete corneal healing after 8 weeks, compared with about 30% of those who received a placebo.”
“In studies, most patients who improved after 8 weeks remained healed throughout the follow-up period, which lasted about a year.”
“the disease can come back in about 14% to 20% of patients after treatment ends.”
“psychiatric events, such as depression and anxiety, made up about 1.2% of all reported side effects for common GLP-1 medications”
“In a 2024 safety analysis, 31,444 adverse side effects were reported by people using semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and tirzepatide (Mounjaro, Zepbound).”
“Of these, 372 (1.2%) were psychiatric effects.”
“The Food and Drug Administration (FDA) has conducted preliminary evaluations of clinical trials and safety reports, and they have not found evidence that using GLP-1 medications causes suicidal thoughts or actions, which are associated wit…”
“A 2024 study found that people with diabetes or obesity using GLP-1 medications were actually less likely to develop depression or suicidal thoughts compared to people not on the drugs.”
“A study analyzing safety reports in a European database found that psychiatric events, such as depression and anxiety, made up about 1.2% of all reported side effects for common GLP-1 medications.”
“Depression was the most commonly reported psychiatric side effect, followed by anxiety.”
“A 2025 study found that healthy weight-loss methods, such as calorie control and exercise, were associated with a lower risk of depression.”
“More extreme methods, such as skipping meals and using diet pills, increased the risk of depression.”
“In a 2024 safety analysis, 31,444 adverse side effects were reported by people using semaglutide (Ozempic, Wegovy), liraglutide (Saxenda, Victoza), and tirzepatide (Mounjaro, Zepbound). Of these, 372 (1.2%) were psychiatric effects. Depres…”
“The percentage of people reporting depression was: The reason tirzepatide had fewer reports of depression than liraglutide or semaglutide may be because it has been on the market for a shorter time.”
“It is also worth noting that many clinical trials for these drugs excluded people with a history of severe psychiatric disorders or recent suicidal thoughts.”
“You should not stop taking Mounjaro without consulting a healthcare professional first, as stopping suddenly may cause unwanted effects.”
“If you experience symptoms of depression or anxiety that last for more than two weeks, interfere with your daily life, or get worse over time, talk with a doctor or a mental health professional.”
“Yes, it is possible that switching GLP-1 medications can help reduce negative side effects as your body may tolerate one GLP-1 better than another. Consult your doctor on which GLP-1 may be best for you.”
“Koselugo (selumetinib) is a Food and Drug Administration (FDA)-approved medication to help treat children with neurofibromatosis type 1 (NF1) who are at least 1 year of age.”
“For Koselugo, a 2026 study showed that the granule formulation was comparable to the capsule and had a manageable safety profile.”
“For Koselugo, if a child does not finish the dose within 30 minutes, the parent should discard what is left of that dose and give the next dose at the scheduled time.”
“If a child misses a dose, a parent should give that dose as soon as possible — unless the next dose is due within 6 hours.”
“A parent can mix Koselugo into 1 to 3 teaspoons of yogurt or specific fruit purees and give it to the child within 30 minutes of mixing.”
“serious diarrhea may start within a day of starting treatment with Onivyde, or it may be start later in treatment.”
“Breyanzi carries a boxed warning for three severe and potentially life threatening reactions.”
“LDL levels were reduced by 10%”
“the intense exposure to oats delivered by the two-day diet elicited a strong response from the gut microbiome.”
“Meta-analyses show that about 3 grams per day of oat beta-glucan, usually from two to three servings of oats or oat bran, can lower LDL by roughly 5–10%”
“over 200 hours of labor are needed to create a batch of modified T-cells”
“up to 48% of the cost of these therapies is due to manufacturing labor”
“the median total costs were over $600,000”
